At the time of writing, Elevance Health Inc [ELV] stock is trading at $434.96, up 0.69%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ELV shares have gain 1.81% over the last week, with a monthly amount glided 9.59%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on March 17, 2025, when Argus upgraded its rating to a Buy but kept the price target unchanged to $450 for it. Previously, Stephens downgraded its rating to Equal-Weight on January 22, 2025, and dropped its price target to $440. On October 18, 2024, downgrade downgraded it’s rating to Hold. BofA Securities downgraded its rating to a Neutral and decreased its price target to $530 on July 18, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $643 as its price target on June 24, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 30, 2024, and assigned it a price target of $649. In a note dated March 06, 2024, Barclays initiated an Overweight rating and provided a target price of $584 on this stock.
For the past year, the stock price of Elevance Health Inc fluctuated between $362.21 and $567.26. Currently, Wall Street analysts expect the stock to reach $525.33 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $434.96 at the most recent close of the market. An investor can expect a potential return of 20.78% based on the average ELV price forecast.
Analyzing the ELV fundamentals
According to Elevance Health Inc [NYSE:ELV], the company’s sales were 176.81B for trailing twelve months, which represents an 6.55% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.14 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.76.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 431.06 points at the first support level, and at 427.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 438.71, and for the 2nd resistance point, it is at 442.47.
Ratios To Look Out For
It is important to note that Elevance Health Inc [NYSE:ELV] has a current ratio of 1.45. Considering the valuation of this stock, the price to sales ratio is 0.56, the price to book ratio is 2.39 and price to earnings (TTM) ratio is 16.98.
Transactions by insiders
Recent insider trading involved Penczek Ronald W, CAO & Controller, that happened on Mar 10 ’25 when 443.0 shares were sold. Officer, Penczek Ronald W completed a deal on Mar 10 ’25 to buy 443.0 shares. Meanwhile, EVP & President, Commercial Kendrick Charles Morgan JR sold 3504.0 shares on Mar 05 ’25.
